GE HealthCare reports Q4 EPS $1.57, adjusted EPS $1.45; guides FY2025 adjusted EPS $4.61-$4.75

GE HealthCare Technologies Inc.

2024-FY EPS reported $4.34 revenue$19,672,000,000

Q4 revenue $5.3B, up 2% organic; net income $720M (13.5% margin) vs $403M (7.7%).
Diluted EPS $1.57 vs $0.88; Adjusted EPS $1.45 vs $1.18; Adjusted EBIT margin 18.7% vs 16.1%.
FY2024 revenue $19.7B (+1% organic); net income $2.0B; diluted EPS $4.34; Adjusted EPS $4.49.
FY2025 guidance: organic revenue growth 2-3%; adjusted EBIT margin 16.7-16.8%; adjusted EPS $4.61-$4.75.
Segment highlights: Advanced Visualization Solutions (+4% organic) and Pharmaceutical Diagnostics (+9%) grew; China weakness noted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.